Not Tagged
Not Tagged
['nhl', 'aml,(-streamline),(-seamless),(-kamloops),(-latamleaders),(-dreamlike)']
dr. chris hourigan will outline the evidence and challenges currently for use of mrd testing in aml to inform treatment decision making and management. learn more during his #ash22 session: 
The official Twitter account for NHLBI DIR, conducting clinical and basic research on the @NIH Bethesda campus. Privacy policy: https://t.co/LxfpA3apOQ